⌘K

Login Start Free

Home/Filings/4/0001209191-23-055434

4//SEC Filing

Longpre Lara 4

Accession 0001209191-23-055434

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 8:13 PM ET

Size

4.8 KB

Accession

0001209191-23-055434

Insider Transaction Report

Form 4

Period: 2023-11-10

Mirum Pharmaceuticals, Inc.MIRM

Chief Development Officer

Transactions

Award
Common Stock
2023-11-10$22.29/sh+434$9,673→ 106,273 total

Footnotes (1)

[F1]This Form 4 is being filed voluntarily to report the acquisition of 434 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780347

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 8:13 PM ET
Size: 4.8 KB

View on SEC.gov